BC Week In Review | Apr 23, 2012
Company News

DFH Pharma deal

DFH and NIH's National Institute of Allergy and Infectious Diseases (NIAID) partnered to develop second generation HIV maturation inhibitor drugs. Under a material evaluation agreement, DFH and NIAID's Division of AIDS (DAIDS) will initially focus...
Items per page:
1 - 1 of 1